Morning Movers with Big News for August 21, 2007
Quite the rough morning for Acura Pharmaceuticals Inc. (OTCBB: ACUR) with the big sell-off coming on the heels of its press release and form 8-K issued late yesterday. Acura Pharmaceuticals entered into a Securities Purchase Agreement (the "Agreement"), with an investor group comprised of Vivo Ventures Fund VI L.P., Vivo Ventures Fund VI Affiliates Fund, L.P., GCE Holdings LLC and certain individual investors (the "Investors"). Pursuant to the Agreement, the Investors purchased 23,605,551 Units ("Units") at a price of $1.08 per Unit with each Unit consisting of four shares of the Company's common stock, $0.01 par value, and a warrant…